Publications

You are here

JCRC continues to conduct her research and publications in HIV vaccines, ART, opportunistic infections, public health and social behaviors. These inform best practices and develop cost effective interventions that will shape national and international policies and guidelines, a number a publications have been published out of JCRC core activities.

Discover more Publications listed here [ All Publications ]

Title Category Issue # Publication Year
AIDS Clinical Trials Group Study A5221. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis Scientific 16 2012
PharmAccess African Studies to Evaluate Resistance (PASER) Investigators. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre Scientific 4 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial Scientific 9 2012
Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study Scientific 2012
PharmAccess African Studies to Evaluate Resistance (PASER). Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa Scientific 11 2012
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults Scientific 2012
PharmAccess African Studies to Evaluate Resistance (PASER). Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies Scientific 11 2012
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe Scientific 4 2012
Response to Antiretroviral Therapy of HIV Type 1-Infected Children in Urban and Rural Settings of Uganda Scientific 12 2012
PharmAccess African Studies to Evaluate Resistance. Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network Scientific 4 2012

Pages